Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| 1 |
Morgan Stanley
MS
|
+$401M |
| 2 |
Enbridge
ENB
|
+$384M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$277M |
| 4 |
Amazon
AMZN
|
+$263M |
| 5 |
Oneok
OKE
|
+$247M |
Top Sells
| 1 |
Toronto Dominion Bank
TD
|
+$431M |
| 2 |
Apple
AAPL
|
+$272M |
| 3 |
GSK
GSK
|
+$236M |
| 4 |
Nucor
NUE
|
+$178M |
| 5 |
MBFI
MB Financial Corp
MBFI
|
+$160M |
Sector Composition
| 1 | Financials | 22.99% |
| 2 | Energy | 9.82% |
| 3 | Technology | 9.61% |
| 4 | Industrials | 8.64% |
| 5 | Healthcare | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPE
551
DELISTED
Callon Petroleum Company
CPE
| $40.7M | 0.02% |
538,859
-6,245
| -1% | -$471K |
|
552
McKesson
MCK
$87.8B
| $40.6M | 0.02% |
347,244
-2,430
| -0.7% | -$284K |
|
553
Monster Beverage
MNST
$61.3B
| $40.6M | 0.02% |
1,488,284
+357,592
| +32% | +$9.76M |
|
554
Cigna
CI
$80.7B
| $40.5M | 0.02% |
251,549
-384,578
| -60% | -$61.8M |
|
555
Regal Rexnord
RRX
$9.39B
| $40.4M | 0.02% |
493,539
+6,882
| +1% | +$563K |
|
556
Republic Services
RSG
$71.3B
| $40.4M | 0.02% |
502,043
-69,426
| -12% | -$5.58M |
|
557
Ducommun
DCO
$1.36B
| $40.2M | 0.02% |
923,334
-43,305
| -4% | -$1.88M |
|
558
Omnicom Group
OMC
$14.7B
| $40M | 0.02% |
547,347
+23,501
| +4% | +$1.72M |
|
559
Nasdaq
NDAQ
$54.3B
| $39.8M | 0.02% |
1,365,282
+603,381
| +79% | +$17.6M |
|
560
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.96B
| – | – |
0
| – | -$34.8M |
|
561
Nice
NICE
$8.77B
| $39.5M | 0.02% |
322,691
-9,813
| -3% | -$1.2M |
|
562
Hershey
HSY
$37.6B
| $39.5M | 0.02% |
344,219
+12,162
| +4% | +$1.4M |
|
563
Vanguard Total International Stock ETF
VXUS
$103B
| $39.3M | 0.02% |
757,432
-130,826
| -15% | -$6.79M |
|
564
iShares US Medical Devices ETF
IHI
$4.24B
| $39.3M | 0.02% |
1,018,170
+180,000
| +21% | +$6.95M |
|
565
Ameren
AEE
$26.8B
| $39.3M | 0.02% |
534,125
+48,108
| +10% | +$3.54M |
|
566
Martin Marietta Materials
MLM
$37.2B
| $39.3M | 0.02% |
195,253
+35,037
| +22% | +$7.05M |
|
567
Brighthouse Financial
BHF
$2.79B
| $39.3M | 0.02% |
1,082,042
-3,048,766
| -74% | -$111M |
|
568
Xylem
XYL
$33.5B
| $39.2M | 0.02% |
496,326
+184,444
| +59% | +$14.6M |
|
569
Amdocs
DOX
$9.23B
| $39.2M | 0.02% |
724,918
-72,212
| -9% | -$3.91M |
|
570
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.06B
| $39.1M | 0.02% |
259,243
+14,324
| +6% | +$2.16M |
|
|
PARA
571
DELISTED
Paramount Global Class B
PARA
| $38.8M | 0.02% |
817,122
+39,151
| +5% | +$1.86M |
|
572
Markel Group
MKL
$24.3B
| $38.8M | 0.02% |
38,962
+3,993
| +11% | +$3.98M |
|
573
ASML
ASML
$312B
| $38.8M | 0.02% |
206,352
+43,911
| +27% | +$8.26M |
|
574
Globus Medical
GMED
$7.89B
| $38.6M | 0.02% |
780,382
-37,562
| -5% | -$1.86M |
|
575
iShares MSCI ACWI ETF
ACWI
$22.3B
| $38.5M | 0.02% |
533,169
-234,488
| -31% | -$16.9M |
|